Antibacterialagent 166 is a derivative of Nitishinone, functioning as a selective and orally active inhibitor of Fusobacterium nucleatum with an MIC50 of 1 µg/mL. It effectively reduces the migration capability of MC-38 cells induced by Fusobacterium nucleatum. Antibacterialagent 166 is a promising lead compound for studying colorectal cancer (CRC) due to its anti-F. nucleatum properties.
Formula:
C11H8ClN3O4
Target:
Antibacterial
* VAT and and shipping costs not included. Errors and price changes excepted
